Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to -$2.1 million.

  • Lipocine's Net Cash Flow fell 1836.64% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82481.0, marking a year-over-year increase of 12501.21%. This contributed to the annual value of $1.4 million for FY2024, which is 1164.9% down from last year.
  • According to the latest figures from Q3 2025, Lipocine's Net Cash Flow is -$2.1 million, which was down 1836.64% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Lipocine's Net Cash Flow registered a high of $2.8 million during Q1 2022, and its lowest value of -$8.6 million during Q1 2021.
  • For the 5-year period, Lipocine's Net Cash Flow averaged around -$1.1 million, with its median value being -$941989.0 (2023).
  • Per our database at Business Quant, Lipocine's Net Cash Flow crashed by 61702.74% in 2021 and then surged by 90687.7% in 2024.
  • Over the past 5 years, Lipocine's Net Cash Flow (Quarter) stood at -$1.6 million in 2021, then surged by 147.97% to $751536.0 in 2022, then fell by 6.98% to $699052.0 in 2023, then surged by 252.33% to $2.5 million in 2024, then plummeted by 187.01% to -$2.1 million in 2025.
  • Its Net Cash Flow was -$2.1 million in Q3 2025, compared to $2.6 million in Q2 2025 and -$2.9 million in Q1 2025.